Page last updated: 2024-11-04

carbonyl cyanide m-chlorophenyl hydrazone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Carbonyl Cyanide m-Chlorophenyl Hydrazone: A proton ionophore. It is commonly used as an uncoupling agent and inhibitor of photosynthesis because of its effects on mitochondrial and chloroplast membranes. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

CCCP : A member of the class of monochlorobenzenes that is benzene substituted by 2-(1,3-dinitrilopropan-2-ylidene)hydrazinyl and chloro groups at positions 1 and 3, respectively. It is a mitochondrial depolarizing agent that induces reactive oxygen species mediated cell death. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID2603
CHEMBL ID224214
CHEBI ID3259
SCHEMBL ID379195
MeSH IDM0003397

Synonyms (84)

Synonym
carbonyl cyanide (m-chlorophenyl)hydrazone
carbonyl cyanide m-chlorophenylhydrazone
m-chlorophenyl carbonylcyanide hydrazone
mesoxalonitrile, (m-chlorophenyl)hydrazone
wln: ncycn&unmr cg
nsc88124
carbonyl cyanide, (3-chlorophenyl)hydrazone
nsc-88124
propanedinitrile, [(3-chlorophenyl)hydrazono]-
wln: ncycn&nunr cg
HMS3266A14
BRD-K15616905-001-01-5
[(3-chlorophenyl)hydrazono]malononitrile
(3-chlorophenyl)hydrazonomalononitrile
carbonylcyanide-3-chlorophenylhydrazone
[(3-chlorophenyl)hydrazono]propanedinitrile
n'-(3-chlorophenyl)carbonohydrazonoyl dicyanide
CHEBI:3259 ,
carbonylcyanide m-chlorophenylhydrazone
2-[(3-chlorophenyl)hydrazono]propanedinitrile
einecs 209-103-7
((3-chlorophenyl)hydrazono)malononitrile
propanedinitrile, ((3-chlorophenyl)hydrazono)-
brn 1842102
carbonylcyanide-m-chlorophenylhydrazone
carbonyl cyanide-m-chlorophenylhydrazone
((3-chlorophenyl)hydrazono)propanedinitrile
carbonyl cyanide, 3-chlorophenylhydrazone
nsc 88124
555-60-2
cccp
carbonyl cyanide m-chlorophenyl hydrazone
carbonyl cyanide 3-chlorophenylhydrazone, >=97% (tlc), powder
NCGC00092273-01
MOLMAP_000008
carbonyl cyanide chlorophenylhydrazone
carbonyl cyanide 3-chlorophenylhydrazone ,
[2-(3-chlorophenyl)hydrazinylidene]propanedinitrile
2-[(3-chlorophenyl)hydrazinylidene]propanedinitrile
bdbm50198893
CHEMBL224214
ugtjljzqqfgtjd-uhfffaoysa-
inchi=1/c9h5cln4/c10-7-2-1-3-8(4-7)13-14-9(5-11)6-12/h1-4,13h
AKOS003238387
NCGC00092273-02
dtxcid5020990
dtxsid7040990 ,
tox21_302066
NCGC00255699-01
cas-555-60-2
4d4nw27cg5 ,
unii-4d4nw27cg5
propanedinitrile, 2-(2-(3-chlorophenyl)hydrazinylidene)-
FT-0623480
S6494
mesoxalonitrile 3-chlorophenylhydrazone
2-[(3-chlorophenyl)hydrazono]malononitrile
2-[(3-chlorophenyl)-hydrazono]malononitrile
carbonylcyanide3-chlorophenylhydrazone
SCHEMBL379195
2-[(3-chlorophenyl)hydrazono]malononitrile #
propanedinitrile, 2-[2-(3-chlorophenyl)hydrazinylidene]-
(3-chlorophenyl)carbonohydrazonoyl dicyanide
c9h5cln4
mfcd00001848
Q2720515
CS-7660
HY-100941
HB5062
carbonyl cyanide m-chlorophenylhydrazone - cas 555-60-2
C2876
2-((3-chlorophenyl)hydrazono)malononitrile
HMS3867E03
EX-A3338
BCP31475
cccp;carbonyl cyanide m-chlorophenylhydrazone;carbonyl cyanide 3-chlorophenylhydrazone; mesoxalonitrile 3-chlorophenylhydrazone
m-cl-ccp [555-60-2]
carbonyl cyanide 3-chlorophenylhydrazone;carbonyl cyanide m-chlorophenylhydrazone
3-chlorophenylhydrazonopropanedinitrile
carbonyl cyanide (3-chlorophenyl)hydrazone
C75608
N-(3-CHLOROPHENYL)CARBONOHYDRAZONOYL DICYANIDE
(3-chlorophenyl)carbonohydrazonoyldicyanide
AS-75696

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" In vitro toxicity is immediate, nonselective among toxic and nontoxic cephalosporins and reversed by substrate excess."( The mitochondrial respiratory toxicity of cephalosporin antibiotics. An inhibitory effect on substrate uptake.
Hsu, CY; Sibley, RK; Tune, BM, 1988
)
0.27
" Respiratory deficiency and pretreatment of cells with antimycin A prevent toxic effects in the late exponential phase of growth, whereas uncouplers and 2mM magnesium salts completely protect even the most vulnerable exponential cells."( Iron toxicity in yeast.
Biliński, T; Krzepiłko, A; Wawryn, J; Wiśnicka, R, 1997
)
0.3
"Acute toxic effects of hexavalent chromium [Cr(VI)], a widely recognised carcinogenic, mutagenic and redox active metal, were investigated in isolated hepatocytes of goldfish (Carassius auratus)."( Acute toxicity of hexavalent chromium in isolated teleost hepatocytes.
Krumschnabel, G; Nawaz, M, 2004
)
0.32
" The analogs 2a and 2b have submicromolar IC(50) values towards human HCT-116 colon cancer cells but are far less toxic to human non-malignant CRL-1790 colon cells."( Mitochondrial dysfunction contributes to the cytotoxicity of some 3,5-bis(benzylidene)-4-piperidone derivatives in colon HCT-116 cells.
Bandy, B; Das, U; Dimmock, JR; Helal, M; Islam, A; Nazarali, AJ, 2013
)
0.39
" Motivated by the sparse solution of our RaMTTSVM, we further propose a safe acceleration rule MSA to accelerate the solving speed."( A novel ramp loss-based multi-task twin support vector machine with multi-parameter safe acceleration.
Pang, X; Xu, Y; Zhao, J, 2022
)
0.72

Bioavailability

ExcerptReferenceRelevance
" Impairment of glucose bioavailability reduced Rh 123 fluorescence."( Mitochondrial membrane potential measurement in rat cerebellar neurons by flow cytometry.
Camarasa, J; Camins, A; Comas, J; Escubedo, E; Gabriel, C; Sureda, FX, 1997
)
0.3

Dosage Studied

ExcerptRelevanceReference
" Leukotrienes, the chemotactic fragment of the fifth component of complement (C5a des arg), N-formyl-L-methionylyl-L-leucyl-L-phenylalanine (FMLP), platelet-activating factor (PAF), and phorbol myristate acetate (PMA) increased the nonadherence of human leukocytes to glass with bell-shaped dose-response curves."( Various authentic chemoattractants mediating leukocyte adherence inhibition.
Thomson, DM, 1984
)
0.27
" From these results and from dose-response curves of QO2 versus uncoupler concentrations, we conclude that 1 microM is an upper limit for free uncoupler concentration in the medium to avoid unwanted side effects during cell physiology studies that require total mitochondrial uncoupling."( Changes in interfacial potentials induced by carbonylcyanide phenylhydrazone uncouplers: possible role in inhibition of mitochondrial oxygen consumption and other transport processes.
Benos, DJ; Reyes, J, 1984
)
0.27
" ATP dose-response experiments, taken together with the effect of cAMP with and without ATP, suggest that phosphorylation is necessary, but not sufficient, for activation."( Regulation of CFTR Cl- conductance in secretion by cellular energy levels.
Bell, CL; Quinton, PM, 1993
)
0.29
" Based on the functional mechanism of iron shown above, we further demonstrate that iron supplementation at a dosage used in iron-deficient patients is sufficient to maximize the anti-tumor effect of clinical ROS-inducing drugs to inhibit xenograft tumor growth and metastasis of melanoma cells through GSDME-dependent pyroptosis."( Tom20 senses iron-activated ROS signaling to promote melanoma cell pyroptosis.
Ai, YL; Chen, HZ; Cheng, K; Han, J; Liu, XS; Sun, RY; Wu, Q; Zhang, JY; Zhou, B; Zhou, D, 2018
)
0.48
" Dissipating the bacterial membrane potential with a sub-lethal dosage of the protonophore, carbonyl cyanide m-chlorophenyl hydrazone, enhanced the tannic acid-cytotoxicity with subsequent inhibition of aerobic respiration in Pseudomonas aeruginosa strains which otherwise exhibited a minimum response to tannic acid."( Membrane Depolarization Sensitizes Pseudomonas aeruginosa Against Tannic Acid.
Aashique, M; Bera, S; Kosuru, RY; Roy, A, 2021
)
0.84
" A linear dose-response curve characterizing the CCCP effects suggested that multiple cellular targets could be affected by the CCCP-induced mitochondrial dysfunctions triggering aneuploidy."( The mitochondrial poison carbonyl cyanide 3-chlorophenyl hydrazone (CCCP) induces aneugenic effects in primary human fibroblasts: a possible link between mitochondrial dysfunction and chromosomal loss.
Crebelli, R; De Battistis, F; Marcon, F; Meschini, R; Siniscalchi, E, 2022
)
0.72
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
geroprotectorAny compound that supports healthy aging, slows the biological aging process, or extends lifespan.
antibacterial agentA substance (or active part thereof) that kills or slows the growth of bacteria.
ionophoreA compound which can carry specific ions through membranes of cells or organelles.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
nitrileA compound having the structure RC#N; thus a C-substituted derivative of hydrocyanic acid, HC#N. In systematic nomenclature, the suffix nitrile denotes the triply bound #N atom, not the carbon atom attached to it.
hydrazoneCompounds having the structure R2C=NNR2, formally derived from aldehydes or ketones by replacing =O by =NNH2 (or substituted analogues).
monochlorobenzenesAny member of the class of chlorobenzenes containing a mono- or poly-substituted benzene ring in which only one substituent is chlorine.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
tetrathionate reductiuon II (to trithionate)08

Protein Targets (69)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, PAPAINCarica papaya (papaya)Potency28.18380.300012.534831.6228AID2161
Chain A, TYROSYL-DNA PHOSPHODIESTERASEHomo sapiens (human)Potency22.38720.004023.8416100.0000AID485290
Chain A, Putative fructose-1,6-bisphosphate aldolaseGiardia intestinalisPotency35.39730.140911.194039.8107AID2451
Chain A, HADH2 proteinHomo sapiens (human)Potency31.62280.025120.237639.8107AID886
Chain B, HADH2 proteinHomo sapiens (human)Potency31.62280.025120.237639.8107AID886
Chain A, Ferritin light chainEquus caballus (horse)Potency56.23415.623417.292931.6228AID485281
Chain A, CruzipainTrypanosoma cruziPotency13.21950.002014.677939.8107AID1476; AID1478; AID2158
LuciferasePhotinus pyralis (common eastern firefly)Potency35.57420.007215.758889.3584AID1224835
acetylcholinesteraseHomo sapiens (human)Potency70.97990.002541.796015,848.9004AID1347395; AID1347397; AID1347399
15-lipoxygenase, partialHomo sapiens (human)Potency25.11890.012610.691788.5700AID887
phosphopantetheinyl transferaseBacillus subtilisPotency56.23410.141337.9142100.0000AID1490
hypoxia-inducible factor 1 alpha subunitHomo sapiens (human)Potency5.89863.189029.884159.4836AID1224846; AID1224894
RAR-related orphan receptor gammaMus musculus (house mouse)Potency0.49510.006038.004119,952.5996AID1159521; AID1159523
SMAD family member 2Homo sapiens (human)Potency8.56340.173734.304761.8120AID1346859; AID1346924
SMAD family member 3Homo sapiens (human)Potency8.56340.173734.304761.8120AID1346859; AID1346924
GLI family zinc finger 3Homo sapiens (human)Potency1.43870.000714.592883.7951AID1259369; AID1259392
Microtubule-associated protein tauHomo sapiens (human)Potency24.56760.180013.557439.8107AID1460; AID1468
AR proteinHomo sapiens (human)Potency1.23140.000221.22318,912.5098AID1259243; AID1259247; AID743035; AID743036; AID743042; AID743053; AID743054; AID743063
thyroid stimulating hormone receptorHomo sapiens (human)Potency0.63100.001318.074339.8107AID926; AID938
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency0.96890.000657.913322,387.1992AID1259378
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency13.50730.001022.650876.6163AID1224838; AID1224839; AID1224893
progesterone receptorHomo sapiens (human)Potency13.68540.000417.946075.1148AID1346795
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency4.23250.000214.376460.0339AID720691; AID720692
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency2.83950.003041.611522,387.1992AID1159552; AID1159555
retinoid X nuclear receptor alphaHomo sapiens (human)Potency10.78060.000817.505159.3239AID1159527; AID1159531
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency0.90410.001530.607315,848.9004AID1224841; AID1224842; AID1224848; AID1224849; AID1259401; AID1259403
farnesoid X nuclear receptorHomo sapiens (human)Potency6.91670.375827.485161.6524AID743217
estrogen nuclear receptor alphaHomo sapiens (human)Potency1.31110.000229.305416,493.5996AID1259244; AID1259248; AID743069; AID743075; AID743078; AID743079; AID743080; AID743091
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency1.73740.001024.504861.6448AID743215
peroxisome proliferator activated receptor gammaHomo sapiens (human)Potency1.46430.001019.414170.9645AID743094; AID743191
vitamin D (1,25- dihydroxyvitamin D3) receptorHomo sapiens (human)Potency6.64270.023723.228263.5986AID743222; AID743223; AID743241
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency2.73060.001723.839378.1014AID743083
activating transcription factor 6Homo sapiens (human)Potency10.96220.143427.612159.8106AID1159516
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_aHomo sapiens (human)Potency7.760619.739145.978464.9432AID1159509
v-jun sarcoma virus 17 oncogene homolog (avian)Homo sapiens (human)Potency13.62720.057821.109761.2679AID1159526; AID1159528
Histone H2A.xCricetulus griseus (Chinese hamster)Potency100.71500.039147.5451146.8240AID1224845
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency0.94130.000323.4451159.6830AID743065; AID743066; AID743067
histone deacetylase 9 isoform 3Homo sapiens (human)Potency25.82120.037617.082361.1927AID1259364; AID1259388
heat shock protein beta-1Homo sapiens (human)Potency2.20170.042027.378961.6448AID743210; AID743228
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency21.41750.000627.21521,122.0200AID743202; AID743219
nuclear receptor ROR-gamma isoform 1Mus musculus (house mouse)Potency0.87650.00798.23321,122.0200AID2546; AID2551
survival motor neuron protein isoform dHomo sapiens (human)Potency7.94330.125912.234435.4813AID1458
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency1.25890.031610.279239.8107AID884; AID885
lethal factor (plasmid)Bacillus anthracis str. A2012Potency2.51190.020010.786931.6228AID912
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency1.25891.000012.224831.6228AID885
Polyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)Potency19.95260.316212.765731.6228AID881
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency1.08710.001557.789015,848.9004AID1259244
Cellular tumor antigen p53Homo sapiens (human)Potency1.77390.002319.595674.0614AID651631; AID720552
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency1.25891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency1.25891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency1.25891.000012.224831.6228AID885
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency1.08710.001551.739315,848.9004AID1259244
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency1.25891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency1.25891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency1.25891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency1.25891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency1.25891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency1.25891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency1.25891.000012.224831.6228AID885
Histamine H2 receptorCavia porcellus (domestic guinea pig)Potency19.95260.00638.235039.8107AID881
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency1.25891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency1.25891.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency1.25891.000012.224831.6228AID885
Inositol monophosphatase 1Rattus norvegicus (Norway rat)Potency3.54811.000010.475628.1838AID1457
GABA theta subunitRattus norvegicus (Norway rat)Potency1.25891.000012.224831.6228AID885
ATPase family AAA domain-containing protein 5Homo sapiens (human)Potency31.10580.011917.942071.5630AID651632; AID720516
Ataxin-2Homo sapiens (human)Potency0.43280.011912.222168.7989AID651632
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency1.25891.000012.224831.6228AID885
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
CDGSH iron-sulfur domain-containing protein 1Homo sapiens (human)IC50 (µMol)35.04000.73103.79949.0780AID1323834
CDGSH iron-sulfur domain-containing protein 1Homo sapiens (human)Ki1.49700.03101.20547.2910AID1323835
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (164)

Processvia Protein(s)Taxonomy
lipid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
phospholipid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
apoptotic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell population proliferationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of macrophage derived foam cell differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonic acid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell migrationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
prostate gland developmentPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
regulation of epithelial cell differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of chemokine productionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of peroxisome proliferator activated receptor signaling pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
positive regulation of keratinocyte differentiationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell cyclePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of growthPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
hepoxilin biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
endocannabinoid signaling pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cannabinoid biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipoxin A4 biosynthetic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleic acid metabolic processPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipid oxidationPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipoxygenase pathwayPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycle G2/M phase transitionCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
ER overload responseCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
mitophagyCellular tumor antigen p53Homo sapiens (human)
in utero embryonic developmentCellular tumor antigen p53Homo sapiens (human)
somitogenesisCellular tumor antigen p53Homo sapiens (human)
release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
hematopoietic progenitor cell differentiationCellular tumor antigen p53Homo sapiens (human)
T cell proliferation involved in immune responseCellular tumor antigen p53Homo sapiens (human)
B cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
T cell lineage commitmentCellular tumor antigen p53Homo sapiens (human)
response to ischemiaCellular tumor antigen p53Homo sapiens (human)
nucleotide-excision repairCellular tumor antigen p53Homo sapiens (human)
double-strand break repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
protein import into nucleusCellular tumor antigen p53Homo sapiens (human)
autophagyCellular tumor antigen p53Homo sapiens (human)
DNA damage responseCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrestCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediatorCellular tumor antigen p53Homo sapiens (human)
transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
Ras protein signal transductionCellular tumor antigen p53Homo sapiens (human)
gastrulationCellular tumor antigen p53Homo sapiens (human)
neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of neuroblast proliferationCellular tumor antigen p53Homo sapiens (human)
protein localizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA replicationCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell population proliferationCellular tumor antigen p53Homo sapiens (human)
determination of adult lifespanCellular tumor antigen p53Homo sapiens (human)
mRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
rRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
response to salt stressCellular tumor antigen p53Homo sapiens (human)
response to inorganic substanceCellular tumor antigen p53Homo sapiens (human)
response to X-rayCellular tumor antigen p53Homo sapiens (human)
response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
positive regulation of gene expressionCellular tumor antigen p53Homo sapiens (human)
cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of cardiac muscle cell apoptotic processCellular tumor antigen p53Homo sapiens (human)
glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
viral processCellular tumor antigen p53Homo sapiens (human)
glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
cerebellum developmentCellular tumor antigen p53Homo sapiens (human)
negative regulation of cell growthCellular tumor antigen p53Homo sapiens (human)
DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
negative regulation of transforming growth factor beta receptor signaling pathwayCellular tumor antigen p53Homo sapiens (human)
mitotic G1 DNA damage checkpoint signalingCellular tumor antigen p53Homo sapiens (human)
negative regulation of telomere maintenance via telomeraseCellular tumor antigen p53Homo sapiens (human)
T cell differentiation in thymusCellular tumor antigen p53Homo sapiens (human)
tumor necrosis factor-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
regulation of tissue remodelingCellular tumor antigen p53Homo sapiens (human)
cellular response to UVCellular tumor antigen p53Homo sapiens (human)
multicellular organism growthCellular tumor antigen p53Homo sapiens (human)
positive regulation of mitochondrial membrane permeabilityCellular tumor antigen p53Homo sapiens (human)
cellular response to glucose starvationCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of apoptotic processCellular tumor antigen p53Homo sapiens (human)
entrainment of circadian clock by photoperiodCellular tumor antigen p53Homo sapiens (human)
mitochondrial DNA repairCellular tumor antigen p53Homo sapiens (human)
regulation of DNA damage response, signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
transcription initiation-coupled chromatin remodelingCellular tumor antigen p53Homo sapiens (human)
negative regulation of proteolysisCellular tumor antigen p53Homo sapiens (human)
negative regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of DNA-templated transcriptionCellular tumor antigen p53Homo sapiens (human)
positive regulation of RNA polymerase II transcription preinitiation complex assemblyCellular tumor antigen p53Homo sapiens (human)
positive regulation of transcription by RNA polymerase IICellular tumor antigen p53Homo sapiens (human)
response to antibioticCellular tumor antigen p53Homo sapiens (human)
fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
negative regulation of fibroblast proliferationCellular tumor antigen p53Homo sapiens (human)
circadian behaviorCellular tumor antigen p53Homo sapiens (human)
bone marrow developmentCellular tumor antigen p53Homo sapiens (human)
embryonic organ developmentCellular tumor antigen p53Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationCellular tumor antigen p53Homo sapiens (human)
protein stabilizationCellular tumor antigen p53Homo sapiens (human)
negative regulation of helicase activityCellular tumor antigen p53Homo sapiens (human)
protein tetramerizationCellular tumor antigen p53Homo sapiens (human)
chromosome organizationCellular tumor antigen p53Homo sapiens (human)
neuron apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of cell cycleCellular tumor antigen p53Homo sapiens (human)
hematopoietic stem cell differentiationCellular tumor antigen p53Homo sapiens (human)
negative regulation of glial cell proliferationCellular tumor antigen p53Homo sapiens (human)
type II interferon-mediated signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cardiac septum morphogenesisCellular tumor antigen p53Homo sapiens (human)
positive regulation of programmed necrotic cell deathCellular tumor antigen p53Homo sapiens (human)
protein-containing complex assemblyCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressCellular tumor antigen p53Homo sapiens (human)
thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of thymocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
necroptotic processCellular tumor antigen p53Homo sapiens (human)
cellular response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
cellular response to xenobiotic stimulusCellular tumor antigen p53Homo sapiens (human)
cellular response to ionizing radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to gamma radiationCellular tumor antigen p53Homo sapiens (human)
cellular response to UV-CCellular tumor antigen p53Homo sapiens (human)
stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
signal transduction by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
cellular response to actinomycin DCellular tumor antigen p53Homo sapiens (human)
positive regulation of release of cytochrome c from mitochondriaCellular tumor antigen p53Homo sapiens (human)
cellular senescenceCellular tumor antigen p53Homo sapiens (human)
replicative senescenceCellular tumor antigen p53Homo sapiens (human)
oxidative stress-induced premature senescenceCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
oligodendrocyte apoptotic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of execution phase of apoptosisCellular tumor antigen p53Homo sapiens (human)
negative regulation of mitophagyCellular tumor antigen p53Homo sapiens (human)
regulation of mitochondrial membrane permeability involved in apoptotic processCellular tumor antigen p53Homo sapiens (human)
regulation of intrinsic apoptotic signaling pathway by p53 class mediatorCellular tumor antigen p53Homo sapiens (human)
positive regulation of miRNA transcriptionCellular tumor antigen p53Homo sapiens (human)
negative regulation of G1 to G0 transitionCellular tumor antigen p53Homo sapiens (human)
negative regulation of miRNA processingCellular tumor antigen p53Homo sapiens (human)
negative regulation of glucose catabolic process to lactate via pyruvateCellular tumor antigen p53Homo sapiens (human)
negative regulation of pentose-phosphate shuntCellular tumor antigen p53Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to hypoxiaCellular tumor antigen p53Homo sapiens (human)
regulation of fibroblast apoptotic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
positive regulation of reactive oxygen species metabolic processCellular tumor antigen p53Homo sapiens (human)
negative regulation of stem cell proliferationCellular tumor antigen p53Homo sapiens (human)
positive regulation of cellular senescenceCellular tumor antigen p53Homo sapiens (human)
positive regulation of intrinsic apoptotic signaling pathwayCellular tumor antigen p53Homo sapiens (human)
cell population proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of B cell proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
nuclear DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
signal transduction in response to DNA damageATPase family AAA domain-containing protein 5Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
isotype switchingATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of isotype switching to IgG isotypesATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloadingATPase family AAA domain-containing protein 5Homo sapiens (human)
regulation of mitotic cell cycle phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of cell cycle G2/M phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of receptor internalizationAtaxin-2Homo sapiens (human)
regulation of translationAtaxin-2Homo sapiens (human)
RNA metabolic processAtaxin-2Homo sapiens (human)
P-body assemblyAtaxin-2Homo sapiens (human)
stress granule assemblyAtaxin-2Homo sapiens (human)
RNA transportAtaxin-2Homo sapiens (human)
regulation of autophagyCDGSH iron-sulfur domain-containing protein 1Homo sapiens (human)
regulation of cellular respirationCDGSH iron-sulfur domain-containing protein 1Homo sapiens (human)
protein maturation by [2Fe-2S] cluster transferCDGSH iron-sulfur domain-containing protein 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (52)

Processvia Protein(s)Taxonomy
iron ion bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
calcium ion bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
protein bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
lipid bindingPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleate 13S-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonate 8(S)-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
arachidonate 15-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
linoleate 9S-lipoxygenase activityPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
transcription cis-regulatory region bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
cis-regulatory region sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
core promoter sequence-specific DNA bindingCellular tumor antigen p53Homo sapiens (human)
TFIID-class transcription factor complex bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription repressor activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificCellular tumor antigen p53Homo sapiens (human)
protease bindingCellular tumor antigen p53Homo sapiens (human)
p53 bindingCellular tumor antigen p53Homo sapiens (human)
DNA bindingCellular tumor antigen p53Homo sapiens (human)
chromatin bindingCellular tumor antigen p53Homo sapiens (human)
DNA-binding transcription factor activityCellular tumor antigen p53Homo sapiens (human)
mRNA 3'-UTR bindingCellular tumor antigen p53Homo sapiens (human)
copper ion bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingCellular tumor antigen p53Homo sapiens (human)
zinc ion bindingCellular tumor antigen p53Homo sapiens (human)
enzyme bindingCellular tumor antigen p53Homo sapiens (human)
receptor tyrosine kinase bindingCellular tumor antigen p53Homo sapiens (human)
ubiquitin protein ligase bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase regulator activityCellular tumor antigen p53Homo sapiens (human)
ATP-dependent DNA/DNA annealing activityCellular tumor antigen p53Homo sapiens (human)
identical protein bindingCellular tumor antigen p53Homo sapiens (human)
histone deacetylase bindingCellular tumor antigen p53Homo sapiens (human)
protein heterodimerization activityCellular tumor antigen p53Homo sapiens (human)
protein-folding chaperone bindingCellular tumor antigen p53Homo sapiens (human)
protein phosphatase 2A bindingCellular tumor antigen p53Homo sapiens (human)
RNA polymerase II-specific DNA-binding transcription factor bindingCellular tumor antigen p53Homo sapiens (human)
14-3-3 protein bindingCellular tumor antigen p53Homo sapiens (human)
MDM2/MDM4 family protein bindingCellular tumor antigen p53Homo sapiens (human)
disordered domain specific bindingCellular tumor antigen p53Homo sapiens (human)
general transcription initiation factor bindingCellular tumor antigen p53Homo sapiens (human)
molecular function activator activityCellular tumor antigen p53Homo sapiens (human)
promoter-specific chromatin bindingCellular tumor antigen p53Homo sapiens (human)
protein bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP hydrolysis activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloader activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
RNA bindingAtaxin-2Homo sapiens (human)
epidermal growth factor receptor bindingAtaxin-2Homo sapiens (human)
protein bindingAtaxin-2Homo sapiens (human)
mRNA bindingAtaxin-2Homo sapiens (human)
pyridoxal phosphate bindingCDGSH iron-sulfur domain-containing protein 1Homo sapiens (human)
identical protein bindingCDGSH iron-sulfur domain-containing protein 1Homo sapiens (human)
protein homodimerization activityCDGSH iron-sulfur domain-containing protein 1Homo sapiens (human)
metal ion bindingCDGSH iron-sulfur domain-containing protein 1Homo sapiens (human)
L-cysteine transaminase activityCDGSH iron-sulfur domain-containing protein 1Homo sapiens (human)
2 iron, 2 sulfur cluster bindingCDGSH iron-sulfur domain-containing protein 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (32)

Processvia Protein(s)Taxonomy
nucleusPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cytosolPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
cytoskeletonPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
plasma membranePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
adherens junctionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
focal adhesionPolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
membranePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
extracellular exosomePolyunsaturated fatty acid lipoxygenase ALOX15BHomo sapiens (human)
nuclear bodyCellular tumor antigen p53Homo sapiens (human)
nucleusCellular tumor antigen p53Homo sapiens (human)
nucleoplasmCellular tumor antigen p53Homo sapiens (human)
replication forkCellular tumor antigen p53Homo sapiens (human)
nucleolusCellular tumor antigen p53Homo sapiens (human)
cytoplasmCellular tumor antigen p53Homo sapiens (human)
mitochondrionCellular tumor antigen p53Homo sapiens (human)
mitochondrial matrixCellular tumor antigen p53Homo sapiens (human)
endoplasmic reticulumCellular tumor antigen p53Homo sapiens (human)
centrosomeCellular tumor antigen p53Homo sapiens (human)
cytosolCellular tumor antigen p53Homo sapiens (human)
nuclear matrixCellular tumor antigen p53Homo sapiens (human)
PML bodyCellular tumor antigen p53Homo sapiens (human)
transcription repressor complexCellular tumor antigen p53Homo sapiens (human)
site of double-strand breakCellular tumor antigen p53Homo sapiens (human)
germ cell nucleusCellular tumor antigen p53Homo sapiens (human)
chromatinCellular tumor antigen p53Homo sapiens (human)
transcription regulator complexCellular tumor antigen p53Homo sapiens (human)
protein-containing complexCellular tumor antigen p53Homo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
Elg1 RFC-like complexATPase family AAA domain-containing protein 5Homo sapiens (human)
nucleusATPase family AAA domain-containing protein 5Homo sapiens (human)
cytoplasmAtaxin-2Homo sapiens (human)
Golgi apparatusAtaxin-2Homo sapiens (human)
trans-Golgi networkAtaxin-2Homo sapiens (human)
cytosolAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
membraneAtaxin-2Homo sapiens (human)
perinuclear region of cytoplasmAtaxin-2Homo sapiens (human)
ribonucleoprotein complexAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
mitochondrionCDGSH iron-sulfur domain-containing protein 1Homo sapiens (human)
mitochondrial outer membraneCDGSH iron-sulfur domain-containing protein 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (204)

Assay IDTitleYearJournalArticle
AID1362719Inhibition of LfrA in Mycobacterium smegmatis MC2 155 ATCC 700084 assessed as decrease in norfloxacin MIC at 0.0004 ug/ml after 72 hrs by MTT assay relative to control2018Bioorganic & medicinal chemistry, 09-15, Volume: 26, Issue:17
Efflux pump inhibition by 11H-pyrido[2,1-b]quinazolin-11-one analogues in mycobacteria.
AID1120500Induction of membrane associated proteins mislocalization in Bacillus subtilis subsp. subtilis str. 168 assessed as reduction in GFP-MinD protein localization by fluorescence assay2013MedChemComm, Jan-01, Volume: 4, Issue:1
Inhibitors of bacterial tubulin target bacterial membranes
AID1519853Mito-toxicity in mitochondria isolated from human RT112 cells assessed as increase in cytochrome C release at 100 uM incubated for 1 hr and measured after 1 to 4 hrs incubation in preservative buffer by Western blot analysis2020European journal of medicinal chemistry, Jan-01, Volume: 185Synthesis, characterization, and biological activity of a triphenylphosphonium-containing imidazolium salt against select bladder cancer cell lines.
AID572147Antimicrobial activity against AcrAB-deficient Escherichia coli AG100AX harboring pBADomeganorM plasmid containing Neisseria gonorrhoeae multidrug efflux pump NorM after 18 to 24 hrs by two fold dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.
AID1676003Hepatotoxicity in human HepG2 cells assessed as concentration required to show 50% cell viability measured after 72 hrs by celltiter 96 aqueous non-Radioactive cell proliferation assay
AID554985Antibacterial activity against Acinetobacter genomosp. 3 isolate 20 by Etest method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Genetic variability among ampC genes from acinetobacter genomic species 3.
AID1063474Antibacterial activity against Bifidobacterium longum ATCC BAA-999 assessed as growth inhibition after 20 to 24 hrs2014Bioorganic & medicinal chemistry letters, Jan-15, Volume: 24, Issue:2
Diarylacylhydrazones: Clostridium-selective antibacterials with activity against stationary-phase cells.
AID1398080Disruption of mitochondrial membrane potential in human HeLa cells assessed as intact mitochondrial membrane at 10 uM after 12 hrs by JC1 staining based flow cytometry (Rvb = 99.2%)2018Bioorganic & medicinal chemistry, 08-07, Volume: 26, Issue:14
Design and biological evaluation of novel hybrids of 1, 5-diarylpyrazole and Chrysin for selective COX-2 inhibition.
AID721858Induction of apoptosis in human U87MG assessed as reduction in mitochondrial membrane potential at 30 uM after 24 hrs by JC-1 staining-based fluorescence microscopy2013Journal of medicinal chemistry, Jan-10, Volume: 56, Issue:1
Toward highly potent cancer agents by modulating the C-2 group of the arylthioindole class of tubulin polymerization inhibitors.
AID1427895Decrease in 1,2'-DiNaphtylAmine efflux in multidrug resistant Enterobacter aerogenes EA289 over-expressing AcrAB-TolC up to 32 uM after 18 hrs measured every 4 sec for 6 mins in presence of glucose by fluorescence assay2017European journal of medicinal chemistry, Feb-15, Volume: 127New amphiphilic neamine conjugates bearing a metal binding motif active against MDR E. aerogenes Gram-negative bacteria.
AID575165Inhibition of acrAB AcrAB-TolC in Escherichia coli K-12 3-AG100 overexpressing acrAB AcrAB-TolC assessed as [3H]TMG accumulation at 200 uM by scintillation counter method2010Antimicrobial agents and chemotherapy, Sep, Volume: 54, Issue:9
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates.
AID1063866Induction of apoptosis in human CCRF-CEM cells assessed as caspase 3 activation at 50 uM after 8 hrs by measuring necrotic cells using flow cytometric analysis relative to control2014Bioorganic & medicinal chemistry, Jan-15, Volume: 22, Issue:2
The cytotoxic effect of 2-acylated-1,4-naphthohydroquinones on leukemia/lymphoma cells.
AID554989Antibacterial activity against Acinetobacter genomosp. 3 isolate 60 by Etest method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Genetic variability among ampC genes from acinetobacter genomic species 3.
AID554991Antibacterial activity against Acinetobacter genomosp. 3 isolate 67 by Etest method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Genetic variability among ampC genes from acinetobacter genomic species 3.
AID1640018Luciferase/luciferin-expressing antifolate-resistant parasites were used to infect a culture of HepG2 cells that were pre-incubated with compounds. Infected hepatocytes emit light due to the luciferase reaction. Assay results are presented as the percent 2018Science (New York, N.Y.), 12-07, Volume: 362, Issue:6419
Open-source discovery of chemical leads for next-generation chemoprotective antimalarials.
AID1120509Increase in bacterial membrane permeability in Bacillus subtilis subsp. subtilis str. 168 at 1 times MIC pre-treated for 5 mins and measured 30 mins post dye addition by propidium iodide dye based flow cytometry2013MedChemComm, Jan-01, Volume: 4, Issue:1
Inhibitors of bacterial tubulin target bacterial membranes
AID555212Antibacterial activity against Acinetobacter genomosp. 3 isolate 128 by Etest method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Genetic variability among ampC genes from acinetobacter genomic species 3.
AID1362714Inhibition of LfrA in Mycobacterium smegmatis MC2 155 ATCC 700084 assessed as decrease in EtBr MIC at 16 ug/ml after 72 hrs by MTT assay relative to control2018Bioorganic & medicinal chemistry, 09-15, Volume: 26, Issue:17
Efflux pump inhibition by 11H-pyrido[2,1-b]quinazolin-11-one analogues in mycobacteria.
AID585838Inhibition of ampD, ampDh2 and ampDh3 deficient Pseudomonas aeruginosa PAO1 AmpC assessed as nitrocefin hydrolyzed per mg of protein at 120 uM by UV spectrophotometry2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.
AID1120513Antimicrobial activity against Bacillus subtilis subsp. subtilis str. 168 after 18 hrs by macro-dilution method2013MedChemComm, Jan-01, Volume: 4, Issue:1
Inhibitors of bacterial tubulin target bacterial membranes
AID1637232Induction of mitochondrial membrane depolarization in human PC3 cells at 3 uM after 24 hrs by JC-1 staining based flow cytometry (Rvb = 4.51%)2016Bioorganic & medicinal chemistry letters, 09-01, Volume: 26, Issue:17
Synthesis and biological evaluation of some novel triazole hybrids of curcumin mimics and their selective anticancer activity against breast and prostate cancer cell lines.
AID1063870Induction of apoptosis in human CCRF-CEM cells using fluorogenic substrate assessed as caspase 3 activation at 50 uM after 8 hrs by measuring late apoptotic cells using flow cytometric analysis relative to control2014Bioorganic & medicinal chemistry, Jan-15, Volume: 22, Issue:2
The cytotoxic effect of 2-acylated-1,4-naphthohydroquinones on leukemia/lymphoma cells.
AID1768866Inhibition of NorA in Staphylococcus aureus SA-1199B assessed as potentiation of norfloxacin-mediated antibacterial activity by measuring norfloxacin MIC incubated for 24 hrs by resazurin assay2021Bioorganic & medicinal chemistry letters, 10-15, Volume: 50Evaluation of Elaiophylin extracted from Streptomyces hygroscopicus as a potential inhibitor of the NorA efflux protein in Staphylococcus aureus: An in vitro and in silico approach.
AID1333439Hepatotoxicity in human HepG2 cells assessed as decrease in cell viability after 48 hrs by PrestoBlue assay2016European journal of medicinal chemistry, Nov-29, Volume: 124Design, synthesis, and biological evaluation of fluorinated imidazo[1,2-a]pyridine derivatives with potential antipsychotic activity.
AID1610937Induction of apoptosis in human A549 cells assessed as low mitochondrial membrane potential after 20 mins by JC-1 staining-based flow cytometric analysis (Rvb = 6.3%)2019Bioorganic & medicinal chemistry, 12-01, Volume: 27, Issue:23
Design, synthesis and biological evaluation of benzoylacrylic acid shikonin ester derivatives as irreversible dual inhibitors of tubulin and EGFR.
AID1333440Hepatotoxicity in human HepG2 cells assessed as cell membrane damage after 24 hrs by luminescence assay2016European journal of medicinal chemistry, Nov-29, Volume: 124Design, synthesis, and biological evaluation of fluorinated imidazo[1,2-a]pyridine derivatives with potential antipsychotic activity.
AID1063470Antibacterial activity against Streptococcus mutans ATCC 700610 assessed as growth inhibition after 20 to 24 hrs2014Bioorganic & medicinal chemistry letters, Jan-15, Volume: 24, Issue:2
Diarylacylhydrazones: Clostridium-selective antibacterials with activity against stationary-phase cells.
AID1481728Activation of FLAG tagged PINK1 (unknown origin) expressed in Flp-In TRex HEK293 cells co-expressed with wild-type Parkin assessed as Parkin Ser65 phosphorylation at 10 uM by immunoblotting analysis2017Journal of medicinal chemistry, 04-27, Volume: 60, Issue:8
Kinetin Riboside and Its ProTides Activate the Parkinson's Disease Associated PTEN-Induced Putative Kinase 1 (PINK1) Independent of Mitochondrial Depolarization.
AID368422Antimicrobial activity against Escherichia coli KAM32 pSTVqepA containing qepA gene ligated to pSTV28 plasmid by agar dilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
AID283566Increase in [3H]testosterone uptake in Escherichia coli AG102 at 100 uM2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Substrate competition studies using whole-cell accumulation assays with the major tripartite multidrug efflux pumps of Escherichia coli.
AID283559Antibacterial activity against Escherichia coli AG102MB after 24 hrs2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Substrate competition studies using whole-cell accumulation assays with the major tripartite multidrug efflux pumps of Escherichia coli.
AID1537032Induction of mitochondrial membrane potential loss in human NB4 cells by JC1 staining based flow cytometry (Rvb = 27.7%)2019Bioorganic & medicinal chemistry, 03-01, Volume: 27, Issue:5
A mitochondria-targeted organic arsenical accelerates mitochondrial metabolic disorder and function injury.
AID1395982Induction of biofilm eradication of methicillin-resistant Staphylococcus aureus 2 after 24 hrs by calgary biofilm device method2018Journal of medicinal chemistry, 05-10, Volume: 61, Issue:9
An Efficient Buchwald-Hartwig/Reductive Cyclization for the Scaffold Diversification of Halogenated Phenazines: Potent Antibacterial Targeting, Biofilm Eradication, and Prodrug Exploration.
AID1313190Cytotoxicity against human HepG2 cells assessed as cell viability after 72 hrs by MTT assay2016Bioorganic & medicinal chemistry letters, 08-01, Volume: 26, Issue:15
Rational design and synthesis of novel anti-prostate cancer agents bearing a 3,5-bis-trifluoromethylphenyl moiety.
AID1304827Antibiofilm activity against methicillin-resistant Staphylococcus aureus isolate 2 assessed as biofilm eradication incubated for 24 hrs by CBD assay2016Journal of medicinal chemistry, 04-28, Volume: 59, Issue:8
Structure-Activity Relationships of a Diverse Class of Halogenated Phenazines That Targets Persistent, Antibiotic-Tolerant Bacterial Biofilms and Mycobacterium tuberculosis.
AID1194558Inhibition of lactose permease in Escherichia coli HN1157 assessed as [3H]TMG accumulation up to 100 uM relative to control2015Bioorganic & medicinal chemistry, May-01, Volume: 23, Issue:9
Structure-activity relationships of a novel pyranopyridine series of Gram-negative bacterial efflux pump inhibitors.
AID521056Antimicrobial activity against Trypanosoma brucei brucei 427 bloodstream form assessed as reduction in mitochondrial membrane potential at 10 uM after 1 min using rhodamine 123 exclusion test2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
The mitochondrion is a site of trypanocidal action of the aromatic diamidine DB75 in bloodstream forms of Trypanosoma brucei.
AID1323834Displacement of [3H]rosiglitazone from recombinant human C-terminal His-tagged MitoNEET cytosolic domain (32 to 108 residues) expressed in Escherichia coli BL21 by scintillation proximity assay2016Bioorganic & medicinal chemistry letters, 11-01, Volume: 26, Issue:21
Identification of small molecules that bind to the mitochondrial protein mitoNEET.
AID581047Induction of bacterial membrane damage in Staphylococcus epidermidis ATCC 23760 at 15 uM by BacLight assay2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Mode of action of Ranbezolid against staphylococci and structural modeling studies of its interaction with ribosomes.
AID762401Inhibition of multidrug resistance efflux pump in Mycobacterium smegmatis MC2 155 ATCC 700084 assessed as EtBr accumulation at 12.5 mg/L measured every 3 mins interval for 45 mins by fluorometric method2013European journal of medicinal chemistry, Aug, Volume: 667-Hydroxy-(E)-3-phenylmethylene-chroman-4-one analogues as efflux pump inhibitors against Mycobacterium smegmatis mc² 155.
AID762410Inhibition of multidrug resistance efflux pump in Mycobacterium smegmatis MC2 155 ATCC 700084 assessed as reduction in EtBr MIC at 16 mg/L by MTT assay relative to control2013European journal of medicinal chemistry, Aug, Volume: 667-Hydroxy-(E)-3-phenylmethylene-chroman-4-one analogues as efflux pump inhibitors against Mycobacterium smegmatis mc² 155.
AID1519855Induction of mitochondrial membrane depolarization in human RT112 cells at 100 uM incubated for 1 hr and measured after 2 hrs recovery time by JC-1 staining based confocal microscopy2020European journal of medicinal chemistry, Jan-01, Volume: 185Synthesis, characterization, and biological activity of a triphenylphosphonium-containing imidazolium salt against select bladder cancer cell lines.
AID613443Inhibition of Staphylococcus aureus K1758 NorA mutant assessed as inhibition of ethidium bromide efflux by measuring increase in fluorescence at 100 uM after 20 mins2011Journal of natural products, Jul-22, Volume: 74, Issue:7
Synergy-directed fractionation of botanical medicines: a case study with goldenseal (Hydrastis canadensis).
AID1254848Induction of apoptosis in human GBM1 cells assessed as loss of mitochondrial membrane potential at 10 uM after 2 hrs by JC-1 staining based fluorescence microscopy2015European journal of medicinal chemistry, Oct-20, Volume: 103Discovery of potent and selective cytotoxic activity of new quinazoline-ureas against TMZ-resistant glioblastoma multiforme (GBM).
AID368418Antimicrobial activity against multidrug-resistant Escherichia coli C316 pHPA containing mutated GyrA gene by agar dilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
AID1635249Cytotoxicity against human HepG2 cells assessed as reduction in cell viability after 72 hrs by MTT assay2016European journal of medicinal chemistry, Aug-08, Volume: 118Design and synthesis of novel bicalutamide and enzalutamide derivatives as antiproliferative agents for the treatment of prostate cancer.
AID1063473Antibacterial activity against Lactobacillus casei ATCC 334 assessed as growth inhibition after 20 to 24 hrs2014Bioorganic & medicinal chemistry letters, Jan-15, Volume: 24, Issue:2
Diarylacylhydrazones: Clostridium-selective antibacterials with activity against stationary-phase cells.
AID1406088Induction of mitochondrial membrane depolarization in human SGC7901 cells assessed as cells with intact mitochondrial membrane potential after 48 hrs by JC-1 staining based flow cytometric analysis (Rvb = 87.3%)2018European journal of medicinal chemistry, Aug-05, Volume: 156Novel curcumin analogue hybrids: Synthesis and anticancer activity.
AID1063873Induction of apoptosis in human CCRF-CEM cells using fluorogenic substrate assessed as caspase 3 activation at 50 uM after 8 hrs by measuring viable cells using flow cytometric analysis (Rvb = 93.9%)2014Bioorganic & medicinal chemistry, Jan-15, Volume: 22, Issue:2
The cytotoxic effect of 2-acylated-1,4-naphthohydroquinones on leukemia/lymphoma cells.
AID1504674Bactericidal activity against Mycobacterium bovis BCG ATCC 35734 assessed as reduction in membrane potential by measuring red to green fluorescent ratio at 100 uM measured at 3 hrs by DiOC2-dye based fluorescence assay2017ACS medicinal chemistry letters, Nov-09, Volume: 8, Issue:11
Indolylalkyltriphenylphosphonium Analogues Are Membrane-Depolarizing Mycobactericidal Agents.
AID585840Inhibition of ampD, ampDh2, ampDh3 and ampG deficient Pseudomonas aeruginosa PAO1 AmpC harboring pZY0901 conferring resistance to gentamycin assessed as nitrocefin hydrolyzed per mg of protein at 120 uM by UV spectrophotometry2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.
AID768462Antimalarial activity against mid to late trophozoite stage of Plasmodium falciparum 3D7 infected in RBC assessed as abnormal mitochondria at 20 uM after 0.5 hrs by MitoTracker Red CMXRos-based fluorescence microscopic analysis relative to untreated contr2013Journal of medicinal chemistry, Aug-08, Volume: 56, Issue:15
Novel conjugated quinoline-indoles compromise Plasmodium falciparum mitochondrial function and show promising antimalarial activity.
AID1891666Inhibition of Multidrug resistance efflux pump in Salmonella enterica serovar typhimurium SL1344 (SE03) assessed as relative fluorescence index using ethidium bromide as substrate at 25 uM by fluorescence based analysis2022Bioorganic & medicinal chemistry letters, 07-01, Volume: 67New diarylpentanoids and chalcones as potential antimicrobial adjuvants.
AID608181Induction of apoptosis in human NTUB1 cells assessed as increase in JC-1 probe monomers at 10 uM after 24 hrs by flow cytometric analysis2011Bioorganic & medicinal chemistry, Jul-15, Volume: 19, Issue:14
18β-Glycyrrhetinic acid derivatives induced mitochondrial-mediated apoptosis through reactive oxygen species-mediated p53 activation in NTUB1 cells.
AID283558Antibacterial activity against Escherichia coli AG102 with marR1 mutation after 24 hrs2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Substrate competition studies using whole-cell accumulation assays with the major tripartite multidrug efflux pumps of Escherichia coli.
AID1063475Antibacterial activity against Bacteroides thetaiotaomicron ATCC 29148 assessed as growth inhibition after 20 to 24 hrs2014Bioorganic & medicinal chemistry letters, Jan-15, Volume: 24, Issue:2
Diarylacylhydrazones: Clostridium-selective antibacterials with activity against stationary-phase cells.
AID1437134Disruption of mitochondrial membrane potential in human NCI-H460 cells at 98 uM up to 1 hr by JC1/DAPI staining based confocal microscopic method2017Bioorganic & medicinal chemistry letters, 02-15, Volume: 27, Issue:4
Synthesis, characterization, in vitro SAR and in vivo evaluation of N,N'bisnaphthylmethyl 2-alkyl substituted imidazolium salts against NSCLC.
AID564973Antimicrobial activity against Mycobacterium bovis BCG by resazurine microtiter assay2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth.
AID572150Antimicrobial activity against AcrAB-deficient Escherichia coli AG100AX harboring pBAD plasmid after 18 to 24 hrs by two fold dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.
AID368424Ratio of MIC for Escherichia coli KAM32 pSTVqepA mutant to MIC for Escherichia coli KAM32 pSTV28 mutant2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
AID572151Antimicrobial activity against AcrAB-deficient Escherichia coli AG100AX harboring pBADomegaydhE plasmid containing Escherichia coli multidrug efflux pump YdhE after 18 to 24 hrs by two fold dilution method2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.
AID1768868Inhibition of NorA in Staphylococcus aureus SA-1199B assessed as potentiation of ethidium bromide-mediated antibacterial activity by measuring ethidium bromide MIC incubated for 24 hrs by resazurin assay2021Bioorganic & medicinal chemistry letters, 10-15, Volume: 50Evaluation of Elaiophylin extracted from Streptomyces hygroscopicus as a potential inhibitor of the NorA efflux protein in Staphylococcus aureus: An in vitro and in silico approach.
AID1333443Hepatotoxicity in human HepG2 cells assessed as intracellular ATP level after 48 hrs by luminescence based ATP detection assay2016European journal of medicinal chemistry, Nov-29, Volume: 124Design, synthesis, and biological evaluation of fluorinated imidazo[1,2-a]pyridine derivatives with potential antipsychotic activity.
AID1333442Hepatotoxicity in human HepG2 cells assessed as intracellular ATP level after 24 hrs by luminescence based ATP detection assay2016European journal of medicinal chemistry, Nov-29, Volume: 124Design, synthesis, and biological evaluation of fluorinated imidazo[1,2-a]pyridine derivatives with potential antipsychotic activity.
AID1333444Hepatotoxicity in human HepG2 cells assessed as loss of mitochondrial membrane potential after 24 hrs by JC-1 staining based fluorescence assay2016European journal of medicinal chemistry, Nov-29, Volume: 124Design, synthesis, and biological evaluation of fluorinated imidazo[1,2-a]pyridine derivatives with potential antipsychotic activity.
AID1585491Cytotoxicity against human HepG2 cells assessed as decrease in cell viability at 10 uM by MTS assay relative to control2018Bioorganic & medicinal chemistry, 12-15, Volume: 26, Issue:23-24
Optimization and preclinical evaluation of novel histamine H
AID564988Antimicrobial activity against Mycobacterium bovis BCG harboring pPAZ23 carrying p27-p55 operon by resazurine microtiter assay2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth.
AID1226062Mitochondrial uncoupling activity in HEK293T/17 cells at 50 uM after 30 mins by TMRE staining-based fluorescence assay2015ACS medicinal chemistry letters, Mar-12, Volume: 6, Issue:3
Exploiting the Polypharmacology of ß-Carbolines to Disrupt O. volvulus Molting.
AID1120507Induction of membrane disruption in mouse C2C12 cells assessed as maximum increase in oxygen consumption rate at 0.6 uM2013MedChemComm, Jan-01, Volume: 4, Issue:1
Inhibitors of bacterial tubulin target bacterial membranes
AID1443450Antimycobacterial activity against Mycobacterium bovis BCG ATCC 35734 assessed as membrane depolarization at 200 uM by DiOC2-based fluorescence assay relative to control2017Journal of medicinal chemistry, 04-13, Volume: 60, Issue:7
Amphiphilic Indole Derivatives as Antimycobacterial Agents: Structure-Activity Relationships and Membrane Targeting Properties.
AID1888850Inhibition of NorA in Staphylococcus aureus 1199B assessed as potentiation of norfloxacin-induced antibacterial activity by measuring Norfloxacin MIC at sub MIC relative to norfloxacin MIC alone2022Bioorganic & medicinal chemistry, 01-15, Volume: 54Potentiating the intracellular killing of Staphylococcus aureus by dihydroquinazoline analogues as NorA efflux pump inhibitor.
AID1063477Antibacterial activity against Clostridium perfringens ATCC 13124 assessed as growth inhibition after 20 to 24 hrs2014Bioorganic & medicinal chemistry letters, Jan-15, Volume: 24, Issue:2
Diarylacylhydrazones: Clostridium-selective antibacterials with activity against stationary-phase cells.
AID1063478Antibacterial activity against Clostridium difficile CD196 assessed as growth inhibition after 20 to 24 hrs2014Bioorganic & medicinal chemistry letters, Jan-15, Volume: 24, Issue:2
Diarylacylhydrazones: Clostridium-selective antibacterials with activity against stationary-phase cells.
AID1164960Antimicrobial activity against against Staphylococcus aureus Newman2014Journal of medicinal chemistry, Oct-23, Volume: 57, Issue:20
Synthesis, structure-activity relationship studies, and antibacterial evaluation of 4-chromanones and chalcones, as well as olympicin A and derivatives.
AID1304831Antibacterial activity against methicillin-resistant Staphylococcus epidermidis ATCC 35984 assessed as biofilm eradication incubated for 24 hrs by CBD assay2016Journal of medicinal chemistry, 04-28, Volume: 59, Issue:8
Structure-Activity Relationships of a Diverse Class of Halogenated Phenazines That Targets Persistent, Antibiotic-Tolerant Bacterial Biofilms and Mycobacterium tuberculosis.
AID1063871Induction of apoptosis in human CCRF-CEM cells using fluorogenic substrate assessed as caspase 3 activation at 50 uM after 8 hrs by measuring early apoptotic cells using flow cytometric analysis (Rvb = 6.1%)2014Bioorganic & medicinal chemistry, Jan-15, Volume: 22, Issue:2
The cytotoxic effect of 2-acylated-1,4-naphthohydroquinones on leukemia/lymphoma cells.
AID1450008Induction of membrane destabilization in Pseudomonas aeruginosa PAO1 assessed as increase in tetracycline uptake at 5 ug/ml measured at 1 min interval for 30 mins by fluorescence assay2017Journal of medicinal chemistry, 05-11, Volume: 60, Issue:9
A Tobramycin Vector Enhances Synergy and Efficacy of Efflux Pump Inhibitors against Multidrug-Resistant Gram-Negative Bacteria.
AID1888854Inhibition of NorA in Staphylococcus aureus 1199B assessed as potentiation of ethidium bromide-induced antibacterial activity by measuring fractional inhibitory concentration2022Bioorganic & medicinal chemistry, 01-15, Volume: 54Potentiating the intracellular killing of Staphylococcus aureus by dihydroquinazoline analogues as NorA efflux pump inhibitor.
AID1138427Induction of collapse in deltapH in Mycobacterium smegmatis inverted membrane vesicles at 30 to 150 uM by 31P NMR spectroscopy2014Journal of medicinal chemistry, Apr-10, Volume: 57, Issue:7
Multitarget drug discovery for tuberculosis and other infectious diseases.
AID1333441Hepatotoxicity in human HepG2 cells assessed as cell membrane damage after 48 hrs by luminescence assay2016European journal of medicinal chemistry, Nov-29, Volume: 124Design, synthesis, and biological evaluation of fluorinated imidazo[1,2-a]pyridine derivatives with potential antipsychotic activity.
AID1637234Induction of mitochondrial membrane depolarization in human MCF7 cells at 10 uM after 24 hrs by JC-1 staining based flow cytometry (Rvb = 11%)2016Bioorganic & medicinal chemistry letters, 09-01, Volume: 26, Issue:17
Synthesis and biological evaluation of some novel triazole hybrids of curcumin mimics and their selective anticancer activity against breast and prostate cancer cell lines.
AID1382489Induction of proton motive force collapse in Escherichia coli inverted membrane vesicle in presence of succinate/O2-driven PMF generation system by ACMA-based fluorescence assay2018European journal of medicinal chemistry, Mar-25, Volume: 148Alkynyl-containing phenylthiazoles: Systemically active antibacterial agents effective against methicillin-resistant Staphylococcus aureus (MRSA).
AID557087Inhibition of multidrug resistance efflux pump in Enterobacter aerogenes isolate 17 assessed as increase in intracellular [14C]chloramphenicol accumulation relative to untreated control2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID1888846Antibacterial activity against Staphylococcus aureus 1199B measured after 24 hrs by Muller Hinton broth based MTT assay2022Bioorganic & medicinal chemistry, 01-15, Volume: 54Potentiating the intracellular killing of Staphylococcus aureus by dihydroquinazoline analogues as NorA efflux pump inhibitor.
AID557086Inhibition of multidrug resistance efflux pump in Enterobacter aerogenes isolate 13 assessed as increase in intracellular [14C]chloramphenicol accumulation relative to untreated control2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID1128692Decrease of mitochondrial transmembrane potential in mouse TA3/Ha cell mitochondria at 0.2 nmol after 5 mins by safranin and JC-1 staining2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
Antiproliferative and uncoupling effects of delocalized, lipophilic, cationic gallic acid derivatives on cancer cell lines. Validation in vivo in singenic mice.
AID1640019Luciferase/luciferin-expressing antifolate-resistant parasites were used to infect a culture of HepG2 cells that were pre-incubated with compounds. Infected hepatocytes emit light due to the luciferase reaction. Assay results are presented as the percent 2018Science (New York, N.Y.), 12-07, Volume: 362, Issue:6419
Open-source discovery of chemical leads for next-generation chemoprotective antimalarials.
AID1600944Induction of apoptosis in human J82 cells assessed as depolarization of mitochondrial membrane potential at 20 uM incubated for 2 hrs by hoechst 33342 staining based fluorescence microscopy2019Bioorganic & medicinal chemistry, 10-01, Volume: 27, Issue:19
The tetrahydroxanthone-dimer phomoxanthone A is a strong inducer of apoptosis in cisplatin-resistant solid cancer cells.
AID557088Inhibition of multidrug resistance efflux pump in Klebsiella pneumoniae isolate 13 assessed as increase in intracellular [14C]chloramphenicol accumulation relative to untreated control2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID572063Inhibition of Acinetobacter baumannii abeS expressed in Escherichia coli KAM32 assessed as decrease in increase in bromide accumulation2009Antimicrobial agents and chemotherapy, Dec, Volume: 53, Issue:12
Role of AbeS, a novel efflux pump of the SMR family of transporters, in resistance to antimicrobial agents in Acinetobacter baumannii.
AID1557847Disruption of proton gradient in Pseudomonas aeruginosa PAO1 membrane assessed as inhibition of tetracycline uptake at 25 uM measured every 1 min for 30 mins by fluorescence based assay2019European journal of medicinal chemistry, Aug-01, Volume: 175Amphiphilic nebramine-based hybrids Rescue legacy antibiotics from intrinsic resistance in multidrug-resistant Gram-negative bacilli.
AID564983Antimicrobial activity against Mycobacterium bovis BCG KOP55 harboring pPAZ23 carrying p27-p55 operon by resazurine microtiter assay2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth.
AID1884095Antibacterial activity against Bacillus cereus ATCC 10987 assessed as reduction in intracellular ATP levels at 100 uM measured upto 120 min by BacTiter-Glo luminescent cell viability assay2022Journal of natural products, 06-24, Volume: 85, Issue:6
Chemically Tuning Resveratrol for the Effective Killing of Gram-Positive Pathogens.
AID1382488Induction of proton motive force collapse in Escherichia coli inverted membrane vesicle in presence of ATP-driven PMF generation system by ACMA-based fluorescence assay2018European journal of medicinal chemistry, Mar-25, Volume: 148Alkynyl-containing phenylthiazoles: Systemically active antibacterial agents effective against methicillin-resistant Staphylococcus aureus (MRSA).
AID581037Induction of bacterial membrane damage in Staphylococcus aureus ATCC 25923 at 15 uM by BacLight assay2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Mode of action of Ranbezolid against staphylococci and structural modeling studies of its interaction with ribosomes.
AID1362739Inhibition of LfrA in Mycobacterium smegmatis MC2 155 ATCC 700084 assessed as increase in norfloxacin accumulation at 12.5 ug/ml measured every 5 mins for 35 mins by fluorometric analysis2018Bioorganic & medicinal chemistry, 09-15, Volume: 26, Issue:17
Efflux pump inhibition by 11H-pyrido[2,1-b]quinazolin-11-one analogues in mycobacteria.
AID584119Inhibition of ethidium bromide accumulation in Escherichia coli KAM32 harboring pSP72 at 100 uM by fluorescence spectrophotometer2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
LmrS is a multidrug efflux pump of the major facilitator superfamily from Staphylococcus aureus.
AID1398079Disruption of mitochondrial membrane potential in human HeLa cells assessed as collapse of the mitochondrial membrane potential at 10 uM after 12 hrs by JC1 staining based flow cytometry (Rvb = 0.768%)2018Bioorganic & medicinal chemistry, 08-07, Volume: 26, Issue:14
Design and biological evaluation of novel hybrids of 1, 5-diarylpyrazole and Chrysin for selective COX-2 inhibition.
AID1063464Cytotoxicity against human FADU cells assessed as concentration required to decrease cell viability incubated for 24 hrs followed by compound washout measured after 18 hrs by resazurin dye-based assay2014Bioorganic & medicinal chemistry letters, Jan-15, Volume: 24, Issue:2
Diarylacylhydrazones: Clostridium-selective antibacterials with activity against stationary-phase cells.
AID584120Inhibition of Staphylococcus aureus LmrS expressed in Escherichia coli KAM32 harboring pSP72 assessed as decrease of ethidium bromide efflux at 0.01 mM after 6 mins by fluorescence spectrophotometer relative to control2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
LmrS is a multidrug efflux pump of the major facilitator superfamily from Staphylococcus aureus.
AID1304844Induction of hemolysis in human RBC at 200 uM incubated for 1 hr2016Journal of medicinal chemistry, 04-28, Volume: 59, Issue:8
Structure-Activity Relationships of a Diverse Class of Halogenated Phenazines That Targets Persistent, Antibiotic-Tolerant Bacterial Biofilms and Mycobacterium tuberculosis.
AID1611013Induction of membrane integrity impairment in methicillin-resistant Staphylococcus aureus ATCC 700699 at 3.125 to 12.5 uM measured for 30 mins by DiOC2(3) probe based fluorescence assay2019Bioorganic & medicinal chemistry, 12-01, Volume: 27, Issue:23
The plant-derived chalcone Xanthoangelol targets the membrane of Gram-positive bacteria.
AID658437Antibacterial activity against Mycobacterium smegmatis mc2 155 after 72 hrs by MTT assay2012Bioorganic & medicinal chemistry, Apr-15, Volume: 20, Issue:8
Compounds of Alpinia katsumadai as potential efflux inhibitors in Mycobacterium smegmatis.
AID557085Inhibition of multidrug resistance efflux pump in Enterobacter aerogenes isolate 6 assessed as increase in intracellular [14C]chloramphenicol accumulation relative to untreated control2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID283567Increase in [3H]testosterone uptake in Escherichia coli AG102MB at 100 uM2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Substrate competition studies using whole-cell accumulation assays with the major tripartite multidrug efflux pumps of Escherichia coli.
AID555213Antibacterial activity against Acinetobacter genomosp. 3 isolate 195 by Etest method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Genetic variability among ampC genes from acinetobacter genomic species 3.
AID1474243Induction of proton motive force collapse in Escherichia coli inverted membrane vesicle in presence of ATP-driven PMF generation system by ACMA-based fluorescence assay2017Journal of medicinal chemistry, 03-23, Volume: 60, Issue:6
Phenylthiazole Antibacterial Agents Targeting Cell Wall Synthesis Exhibit Potent Activity in Vitro and in Vivo against Vancomycin-Resistant Enterococci.
AID521052Antimicrobial activity against Trypanosoma brucei brucei 427 bloodstream form assessed as reduction in mitochondrial membrane potential at 10 uM after 5 mins using rhodamine 123 exclusion test relative to control2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
The mitochondrion is a site of trypanocidal action of the aromatic diamidine DB75 in bloodstream forms of Trypanosoma brucei.
AID1395985Bactericidal activity against methicillin-resistant Staphylococcus epidermidis ATCC 35984 planktonic cells after 24 hrs by calgary biofilm device method2018Journal of medicinal chemistry, 05-10, Volume: 61, Issue:9
An Efficient Buchwald-Hartwig/Reductive Cyclization for the Scaffold Diversification of Halogenated Phenazines: Potent Antibacterial Targeting, Biofilm Eradication, and Prodrug Exploration.
AID762409Antimicrobial activity against Mycobacterium smegmatis MC2 155 ATCC 700084 at 16 mg/L after 72 hrs by MTT assay in presence of EtBr2013European journal of medicinal chemistry, Aug, Volume: 667-Hydroxy-(E)-3-phenylmethylene-chroman-4-one analogues as efflux pump inhibitors against Mycobacterium smegmatis mc² 155.
AID521058Antimicrobial activity against Trypanosoma brucei brucei 427 bloodstream form assessed as inhibition of mitochondrial ATPase activity at 50 uM after 10 mins2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
The mitochondrion is a site of trypanocidal action of the aromatic diamidine DB75 in bloodstream forms of Trypanosoma brucei.
AID1600945Induction of apoptosis in cisplatin resistant human J82 cells assessed as depolarization of mitochondrial membrane potential at 20 uM incubated for 2 hrs by hoechst 33342 staining based fluorescence microscopy2019Bioorganic & medicinal chemistry, 10-01, Volume: 27, Issue:19
The tetrahydroxanthone-dimer phomoxanthone A is a strong inducer of apoptosis in cisplatin-resistant solid cancer cells.
AID1063472Antibacterial activity against Lactobacillus reuteri ATCC 23272 assessed as growth inhibition after 20 to 24 hrs2014Bioorganic & medicinal chemistry letters, Jan-15, Volume: 24, Issue:2
Diarylacylhydrazones: Clostridium-selective antibacterials with activity against stationary-phase cells.
AID1888849Inhibition of NorA in Staphylococcus aureus 1199B assessed as potentiation of norfloxacin-induced antibacterial activity by measuring Norfloxacin MIC at sub MIC2022Bioorganic & medicinal chemistry, 01-15, Volume: 54Potentiating the intracellular killing of Staphylococcus aureus by dihydroquinazoline analogues as NorA efflux pump inhibitor.
AID554986Antibacterial activity against Acinetobacter genomosp. 3 isolate 21 by Etest method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Genetic variability among ampC genes from acinetobacter genomic species 3.
AID1891665Inhibition of Multidrug resistance efflux pump in Staphylococcus aureus 272123 assessed as relative fluorescence index using ethidium bromide as substrate at 25 uM by fluorescence based analysis2022Bioorganic & medicinal chemistry letters, 07-01, Volume: 67New diarylpentanoids and chalcones as potential antimicrobial adjuvants.
AID572153Inhibition of Escherichia coli K-12 multidrug efflux protein YdhE expressed in Escherichia coli AG100AX assessed as assessed as increase in Norfloxacin accumulation at 100 uM after 15 mins by fluorimetric assay2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.
AID1867980Inhibition of efflux pump in Gram-negative Escherichia coli K-12 AG100 expressing AcrAB-TolC efflux pump assessed as relative fluorescence index using ethidium bromide as substrate at 50 uM and measured after 1 hr by fluorescence based microtiter plate re2022European journal of medicinal chemistry, Jul-05, Volume: 237Application of partially aromatic ortho-quionone-methides for the synthesis of novel naphthoxazines with improved antibacterial activity.
AID1610941Induction of apoptosis in human A549 cells assessed as high mitochondrial membrane potential after 20 mins by JC-1 staining-based flow cytometric analysis (Rvb = 90.6%)2019Bioorganic & medicinal chemistry, 12-01, Volume: 27, Issue:23
Design, synthesis and biological evaluation of benzoylacrylic acid shikonin ester derivatives as irreversible dual inhibitors of tubulin and EGFR.
AID555211Antibacterial activity against Acinetobacter genomosp. 3 isolate 109 by Etest method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Genetic variability among ampC genes from acinetobacter genomic species 3.
AID1063469Antibacterial activity against Escherichia coli ATCC 700927 assessed as growth inhibition after 20 to 24 hrs2014Bioorganic & medicinal chemistry letters, Jan-15, Volume: 24, Issue:2
Diarylacylhydrazones: Clostridium-selective antibacterials with activity against stationary-phase cells.
AID1183918Reduction in metabolic activity in mitochondria isolated from human MONO-MAC-6 cells after 3 hrs at 10 uM by MTT assay2014Bioorganic & medicinal chemistry, Aug-01, Volume: 22, Issue:15
Melleolides induce rapid cell death in human primary monocytes and cancer cells.
AID1063471Antibacterial activity against Staphylococcus aureus 8325-4 assessed as growth inhibition after 20 to 24 hrs2014Bioorganic & medicinal chemistry letters, Jan-15, Volume: 24, Issue:2
Diarylacylhydrazones: Clostridium-selective antibacterials with activity against stationary-phase cells.
AID555208Antibacterial activity against Acinetobacter genomosp. 3 isolate 69 by Etest method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Genetic variability among ampC genes from acinetobacter genomic species 3.
AID572155Inhibition of Escherichia coli K-12 multidrug efflux protein YdhE expressed in Escherichia coli AG100AX assessed as assessed as increase in ethidium bromide accumulation at 100 uM after 15 mins by fluorimetric assay2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.
AID584115Antibacterial activity against Escherichia coli KAM32 harboring pSP72 by broth microdilution method2010Antimicrobial agents and chemotherapy, Dec, Volume: 54, Issue:12
LmrS is a multidrug efflux pump of the major facilitator superfamily from Staphylococcus aureus.
AID726457Reduction in mitochondria membrane potential in human HCT116 cells measured as fluorescence units at 1 uM after 48 hrs by JC-1 dye (negative control = 3069 +/- 20 Flu_intensity)2013Bioorganic & medicinal chemistry letters, Feb-15, Volume: 23, Issue:4
Mitochondrial dysfunction contributes to the cytotoxicity of some 3,5-bis(benzylidene)-4-piperidone derivatives in colon HCT-116 cells.
AID537736Antifungal activity against yeast AD1-8u expressing Candida albicans CaCdr1p by agar disk diffusion assay2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
AID1362713Growth inhibition of Mycobacterium smegmatis MC2 155 ATCC 700084 after 72 hrs by MTT assay2018Bioorganic & medicinal chemistry, 09-15, Volume: 26, Issue:17
Efflux pump inhibition by 11H-pyrido[2,1-b]quinazolin-11-one analogues in mycobacteria.
AID1063468Antibacterial activity against Enterococcus faecalis ATCC 47077 assessed as growth inhibition after 20 to 24 hrs2014Bioorganic & medicinal chemistry letters, Jan-15, Volume: 24, Issue:2
Diarylacylhydrazones: Clostridium-selective antibacterials with activity against stationary-phase cells.
AID555214Antibacterial activity against Acinetobacter genomosp. 3 isolate 243 by Etest method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Genetic variability among ampC genes from acinetobacter genomic species 3.
AID537735Binding affinity to Candida albicans CaMdr1p expressed in yeast AD1-8u2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
AID1778847Induction of mitochondrial membrane potential dysfunction in Leishmania donovani MHOM/IN/80/Dd8 promastigotes assessed as cells with mitochondrial depolarization at 50 uM incubated for 72 hrs by JC1 staining based flow cytometry (Rvb = 3.63%)2021European journal of medicinal chemistry, Oct-05, Volume: 221Design, synthesis, in vitro and in vivo biological evaluation of pyranone-piperazine analogs as potent antileishmanial agents.
AID1406087Induction of mitochondrial membrane depolarization in human SGC7901 cells assessed as cells with mitochondrial membrane potential loss after 48 hrs by JC-1 staining based flow cytometric analysis (Rvb = 9.29%)2018European journal of medicinal chemistry, Aug-05, Volume: 156Novel curcumin analogue hybrids: Synthesis and anticancer activity.
AID1888853Inhibition of NorA in Staphylococcus aureus 1199B assessed as potentiation of ethidium bromide-induced antibacterial activity by measuring ethidium bromide MIC at sub MIC relative to ethidium bromide MIC alone2022Bioorganic & medicinal chemistry, 01-15, Volume: 54Potentiating the intracellular killing of Staphylococcus aureus by dihydroquinazoline analogues as NorA efflux pump inhibitor.
AID1120508Induction of membrane disruption in mouse C2C12 cells assessed as increase in oxygen consumption rate at 0.1 to 1.2 uM2013MedChemComm, Jan-01, Volume: 4, Issue:1
Inhibitors of bacterial tubulin target bacterial membranes
AID1413432Cytotoxicity against human HepG2 cells assessed as reduction in cell viability at 10 uM after 72 hrs by MTS assay
AID1504668Bactericidal activity against Mycobacterium bovis BCG ATCC 35734 assessed as suppression of reductive capacity by measuring decrease in formazan formation at 100 uM after 0.5 to 1 hr by MTT reduction assay2017ACS medicinal chemistry letters, Nov-09, Volume: 8, Issue:11
Indolylalkyltriphenylphosphonium Analogues Are Membrane-Depolarizing Mycobactericidal Agents.
AID1333438Hepatotoxicity in human HepG2 cells assessed as decrease in cell viability after 24 hrs by PrestoBlue assay2016European journal of medicinal chemistry, Nov-29, Volume: 124Design, synthesis, and biological evaluation of fluorinated imidazo[1,2-a]pyridine derivatives with potential antipsychotic activity.
AID762417Antimicrobial activity against Mycobacterium smegmatis MC2 155 ATCC 700084 after 72 hrs by MTT assay2013European journal of medicinal chemistry, Aug, Volume: 667-Hydroxy-(E)-3-phenylmethylene-chroman-4-one analogues as efflux pump inhibitors against Mycobacterium smegmatis mc² 155.
AID1768867Inhibition of NorA in Staphylococcus aureus SA-1199 assessed as potentiation of ethidium bromide-mediated antibacterial activity by measuring ethidium bromide MIC incubated for 24 hrs by resazurin assay2021Bioorganic & medicinal chemistry letters, 10-15, Volume: 50Evaluation of Elaiophylin extracted from Streptomyces hygroscopicus as a potential inhibitor of the NorA efflux protein in Staphylococcus aureus: An in vitro and in silico approach.
AID283568Increase in [3H]testosterone uptake in Escherichia coli HNCE4 at 100 uM2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Substrate competition studies using whole-cell accumulation assays with the major tripartite multidrug efflux pumps of Escherichia coli.
AID368419Antimicrobial activity against Escherichia coli KAM32 expressing deltaacrB ydhE hsd gene by agar dilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
AID539240Effect on multidrug resistance protein-mediated Rhodamine 123 drug uptake in blood stage of Plasmodium berghei NK65 mitochondria infected ICR mice (Mus musculus) RBCs at 10 uM after 20 min by fluorescence microscopy2010Bioorganic & medicinal chemistry, Nov-15, Volume: 18, Issue:22
Selective accumulation of a novel antimalarial rhodacyanine derivative, SSJ-127, in an organelle of Plasmodium berghei.
AID1474244Induction of proton motive force collapse in Escherichia coli inverted membrane vesicle in presence of succinate/O2-driven PMF generation system by ACMA-based fluorescence assay2017Journal of medicinal chemistry, 03-23, Volume: 60, Issue:6
Phenylthiazole Antibacterial Agents Targeting Cell Wall Synthesis Exhibit Potent Activity in Vitro and in Vivo against Vancomycin-Resistant Enterococci.
AID1120502Protonophore activity in Bacillus subtilis subsp. subtilis str. 168 assessed as induction of rapid equlibration of delta-pH at 1 times MIC2013MedChemComm, Jan-01, Volume: 4, Issue:1
Inhibitors of bacterial tubulin target bacterial membranes
AID283560Antibacterial activity against Escherichia coli HNCE4 after 24 hrs2007Antimicrobial agents and chemotherapy, Mar, Volume: 51, Issue:3
Substrate competition studies using whole-cell accumulation assays with the major tripartite multidrug efflux pumps of Escherichia coli.
AID613442Inhibition of wild type Staphylococcus aureus NCTC8325-4 NorA assessed as time taken to inhibit ethidium bromide efflux by measuring fluorescence at 100 uM relative to control2011Journal of natural products, Jul-22, Volume: 74, Issue:7
Synergy-directed fractionation of botanical medicines: a case study with goldenseal (Hydrastis canadensis).
AID1609695Induction of mitochondrial dysfunction in Leishmania donovani promastigotes assessed as reduction in mitochondrial membrane potential at 50 uM after 15 mins by JC-1 staining-based flow cytometric analysis (Rvb = 7.73%)2019European journal of medicinal chemistry, Nov-15, Volume: 182β-Amino acid derivatives as mitochondrial complex III inhibitors of L. donovani: A promising chemotype targeting visceral leishmaniasis.
AID554984Antibacterial activity against Acinetobacter genomosp. 3 isolate 14 by Etest method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Genetic variability among ampC genes from acinetobacter genomic species 3.
AID608198Induction of apoptosis in human NTUB1 cells assessed as decrease in JC-1 aggregation at 10 uM after 24 hrs by flow cytometric analysis2011Bioorganic & medicinal chemistry, Jul-15, Volume: 19, Issue:14
18β-Glycyrrhetinic acid derivatives induced mitochondrial-mediated apoptosis through reactive oxygen species-mediated p53 activation in NTUB1 cells.
AID537733Binding affinity to Candida albicans CaCdr1p expressed in yeast AD1-8u2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
AID1512655Mitochondrial uncoupling activity in mouse liver mitochondria assessed as effect on succinoxldase coupled phosphorylation2018Journal of medicinal chemistry, 06-14, Volume: 61, Issue:11
Small Molecule Mitochondrial Uncouplers and Their Therapeutic Potential.
AID1413433Cytotoxicity against HEK293 cells assessed as reduction in cell viability at 10 uM after 72 hrs by MTS assay
AID585839Inhibition of ampD, ampDh2, ampDh3 and ampG deficient Pseudomonas aeruginosa PAO1 AmpC assessed as nitrocefin hydrolyzed per mg of protein at 120 uM by UV spectrophotometry2010Antimicrobial agents and chemotherapy, Nov, Volume: 54, Issue:11
ampG gene of Pseudomonas aeruginosa and its role in β-lactamase expression.
AID1600953Induction of apoptosis in human A2780 cells assessed as decrease in mitochondrial membrane potential at 20 uM incubated for 24 hrs by TMRE staining based flow cytometry2019Bioorganic & medicinal chemistry, 10-01, Volume: 27, Issue:19
The tetrahydroxanthone-dimer phomoxanthone A is a strong inducer of apoptosis in cisplatin-resistant solid cancer cells.
AID704585Antitubercular activity against Mycobacterium tuberculosis H37Rv assessed as disruption of membrane potential at 5 uM after 20 mins at pH 7.4 by DiOC2-based spectrofluorimetric analysis
AID564978Antimicrobial activity against Mycobacterium bovis BCG KOP55 harboring inactivated p55 gene by resazurine microtiter assay2009Antimicrobial agents and chemotherapy, Sep, Volume: 53, Issue:9
Role of the Mycobacterium tuberculosis P55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth.
AID1063466Antibacterial activity against stationary phase of Clostridium difficile CD196 assessed as cell killing at 1 to 20 X MIC after 3 to 6 hrs2014Bioorganic & medicinal chemistry letters, Jan-15, Volume: 24, Issue:2
Diarylacylhydrazones: Clostridium-selective antibacterials with activity against stationary-phase cells.
AID1671830Induction of mitochondrial membrane depolarization in human MDA-MB-231 cells at 10 uM measured after 24 hrs by JC-1 staining based flow cytometry analysis (Rvb = 0.89 to 3.24 %)2019European journal of medicinal chemistry, Apr-01, Volume: 167Pyranocarbazole derivatives as potent anti-cancer agents triggering tubulin polymerization stabilization induced activation of caspase-dependent apoptosis and downregulation of Akt/mTOR in breast cancer cells.
AID1600954Induction of apoptosis in human A2780cisR cells assessed as decrease in mitochondrial membrane potential at 20 uM incubated for 24 hrs by TMRE staining based flow cytometry2019Bioorganic & medicinal chemistry, 10-01, Volume: 27, Issue:19
The tetrahydroxanthone-dimer phomoxanthone A is a strong inducer of apoptosis in cisplatin-resistant solid cancer cells.
AID557089Inhibition of multidrug resistance efflux pump in Klebsiella pneumoniae isolate 14 assessed as increase in intracellular [14C]chloramphenicol accumulation relative to untreated control2009Antimicrobial agents and chemotherapy, Apr, Volume: 53, Issue:4
Occurrence of efflux mechanism and cephalosporinase variant in a population of Enterobacter aerogenes and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
AID1161122Bactericidal activity against Mycobacterium smegmatis at 500 uM after 3 to 24 hrs by colony forming unit count method2014Bioorganic & medicinal chemistry, Oct-01, Volume: 22, Issue:19
Incorporation of triphenylphosphonium functionality improves the inhibitory properties of phenothiazine derivatives in Mycobacterium tuberculosis.
AID1362736Inhibition of LfrA in Mycobacterium smegmatis MC2 155 ATCC 700084 assessed as increase in EtBr accumulation at 12.5 ug/ml measured every 5 mins for 35 mins by fluorometric analysis2018Bioorganic & medicinal chemistry, 09-15, Volume: 26, Issue:17
Efflux pump inhibition by 11H-pyrido[2,1-b]quinazolin-11-one analogues in mycobacteria.
AID572152Inhibition of Neisseria gonorrhoeae FA19 multidrug efflux protein NorM expressed in Escherichia coli AG100AX assessed as increase in Norfloxacin accumulation at 100 uM after 15 mins by fluorimetric assay2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.
AID1120511Induction of transmembrane potential loss in Bacillus subtilis subsp. subtilis str. 168 assessed as lambda575/lambda530 fluorescence emission intensity ratio at 1 times MIC pre-treated for 5 mins and measured 15 mins post dye addition by DiOC2 dye based f2013MedChemComm, Jan-01, Volume: 4, Issue:1
Inhibitors of bacterial tubulin target bacterial membranes
AID1286336Increase in mitochondrial oxygen consumption in human HT-29 cells measured for 20 to 60 mins by time-resolved fluorescence assay2016Journal of natural products, Jan-22, Volume: 79, Issue:1
Amorfrutin C Induces Apoptosis and Inhibits Proliferation in Colon Cancer Cells through Targeting Mitochondria.
AID555209Antibacterial activity against Acinetobacter genomosp. 3 isolate 90 by Etest method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Genetic variability among ampC genes from acinetobacter genomic species 3.
AID1599269Induction of mitochondrial potential loss in Leishmania donovani MHOM/IN/80/Dd8 promastigotes assessed as shift in red to green fluorescence at 50 uM by JC1 dye-based flow cytometry (Rvb = 7.37%)2019Journal of medicinal chemistry, 06-13, Volume: 62, Issue:11
Synthesis, Biological Evaluation, Structure-Activity Relationship, and Mechanism of Action Studies of Quinoline-Metronidazole Derivatives Against Experimental Visceral Leishmaniasis.
AID368425Inhibition of qepA-mediated drug efflux in Escherichia coli KAM32 assessed as increase in accumulation of Norfloxacin by fluorescence spectroscopy2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
AID1768865Inhibition of NorA in Staphylococcus aureus SA-1199 assessed as potentiation of norfloxacin-mediated antibacterial activity by measuring norfloxacin MIC incubated for 24 hrs by resazurin assay2021Bioorganic & medicinal chemistry letters, 10-15, Volume: 50Evaluation of Elaiophylin extracted from Streptomyces hygroscopicus as a potential inhibitor of the NorA efflux protein in Staphylococcus aureus: An in vitro and in silico approach.
AID1571101Cytotoxicity against HEK293 cells assessed as reduction in cell viability at 1 uM after 48 hrs by MTT assay relative to control2018MedChemComm, Nov-01, Volume: 9, Issue:11
Search for a 5-CT alternative.
AID1063876Cytotoxicity against human CCRF-CEM cells assessed as mitochondrial membrane depolarization at 50 uM after 8 hrs by JC-1 red/green staining-based flow cytometry analysis (Rvb = 3.3%)2014Bioorganic & medicinal chemistry, Jan-15, Volume: 22, Issue:2
The cytotoxic effect of 2-acylated-1,4-naphthohydroquinones on leukemia/lymphoma cells.
AID1395986Induction of biofilm eradication of methicillin-resistant Staphylococcus epidermidis ATCC 35984 after 24 hrs by calgary biofilm device method2018Journal of medicinal chemistry, 05-10, Volume: 61, Issue:9
An Efficient Buchwald-Hartwig/Reductive Cyclization for the Scaffold Diversification of Halogenated Phenazines: Potent Antibacterial Targeting, Biofilm Eradication, and Prodrug Exploration.
AID1888883Inhibition of NorA in Staphylococcus aureus 1199B assessed as accumulation of ethidium bromide at 2.5 ug/ml by measuring fluorescence intensity measured at 5 mins interval for 40 mins by fluorescence spectrophotometry2022Bioorganic & medicinal chemistry, 01-15, Volume: 54Potentiating the intracellular killing of Staphylococcus aureus by dihydroquinazoline analogues as NorA efflux pump inhibitor.
AID1063463Cytotoxicity against human HepG2 cells assessed as concentration required to decrease cell viability incubated for 24 hrs followed by compound washout measured after 18 hrs by resazurin dye-based assay2014Bioorganic & medicinal chemistry letters, Jan-15, Volume: 24, Issue:2
Diarylacylhydrazones: Clostridium-selective antibacterials with activity against stationary-phase cells.
AID1888851Inhibition of NorA in Staphylococcus aureus 1199B assessed as potentiation of norfloxacin-induced antibacterial activity by measuring fractional inhibitory concentration2022Bioorganic & medicinal chemistry, 01-15, Volume: 54Potentiating the intracellular killing of Staphylococcus aureus by dihydroquinazoline analogues as NorA efflux pump inhibitor.
AID1063868Cytotoxicity against human CCRF-CEM cells assessed as intact mitochondrial membrane potential at 50 uM after 8 hrs by JC-1 red/green staining-based flow cytometry analysis (Rvb = 96.7%)2014Bioorganic & medicinal chemistry, Jan-15, Volume: 22, Issue:2
The cytotoxic effect of 2-acylated-1,4-naphthohydroquinones on leukemia/lymphoma cells.
AID1888852Inhibition of NorA in Staphylococcus aureus 1199B assessed as potentiation of ethidium bromide-induced antibacterial activity by measuring ethidium bromide MIC at sub MIC2022Bioorganic & medicinal chemistry, 01-15, Volume: 54Potentiating the intracellular killing of Staphylococcus aureus by dihydroquinazoline analogues as NorA efflux pump inhibitor.
AID1888879Inhibition of NorA in Staphylococcus aureus 1199B assessed as accumulation of norfloxacin at 2.5 ug/ml by measuring fluorescence intensity measured at 5 mins interval for 40 mins by fluorescence spectrophotometry2022Bioorganic & medicinal chemistry, 01-15, Volume: 54Potentiating the intracellular killing of Staphylococcus aureus by dihydroquinazoline analogues as NorA efflux pump inhibitor.
AID1374540Cytotoxicity against human HepG2 cells assessed as ATP level at 10 uM after 120 mins by bioluminescence-based assay relative to control2018Bioorganic & medicinal chemistry letters, 03-01, Volume: 28, Issue:5
MF-8, a novel promising arylpiperazine-hydantoin based 5-HT
AID554988Antibacterial activity against Acinetobacter genomosp. 3 isolate 56 by Etest method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Genetic variability among ampC genes from acinetobacter genomic species 3.
AID554987Antibacterial activity against Acinetobacter genomosp. 3 isolate 52 by Etest method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Genetic variability among ampC genes from acinetobacter genomic species 3.
AID1158759Drug accumulation in Caenorhabditis elegans at 10 uM after 6 hrs by LC-MS analysis2014Journal of medicinal chemistry, Jul-10, Volume: 57, Issue:13
Dual protonophore-chitinase inhibitors dramatically affect O. volvulus molting.
AID1158767Antiparasitic activity against Onchocerca volvulus assessed as inhibition of L3 to L4 larval molting at 10 uM for 24 hrs measured until 6 days by using inverted microscopic analysis in presence of PBMC2014Journal of medicinal chemistry, Jul-10, Volume: 57, Issue:13
Dual protonophore-chitinase inhibitors dramatically affect O. volvulus molting.
AID1395981Bactericidal activity against methicillin-resistant Staphylococcus aureus 2 planktonic cells after 24 hrs by calgary biofilm device method2018Journal of medicinal chemistry, 05-10, Volume: 61, Issue:9
An Efficient Buchwald-Hartwig/Reductive Cyclization for the Scaffold Diversification of Halogenated Phenazines: Potent Antibacterial Targeting, Biofilm Eradication, and Prodrug Exploration.
AID1390874Inhibition of mitochondrial respiratory complex 1 in differentiated Sprague-Dawley rat L6 myotube cells assessed as mitochondrial membrane potential at 10 uM after 40 to 60 mins by JC-1 staining based fluorescence assay (Rvb = 100 +/- 1.6%)2018Bioorganic & medicinal chemistry, 05-01, Volume: 26, Issue:8
Design, synthesis, and structure-activity relationships of novel 4,7,12,12a-tetrahydro-5H-thieno[3',2':3,4]pyrido[1,2-b]isoquinoline and 5,8,12,12a-tetrahydro-6H-thieno[2',3':4,5]pyrido[2,1-a]isoquinoline derivatives as cellular activators of adenosine 5'
AID368420Antimicrobial activity against Escherichia coli KAM32 pHPA containing mutated GyrA gene by agar dilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
AID555210Antibacterial activity against Acinetobacter genomosp. 3 isolate 103 by Etest method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Genetic variability among ampC genes from acinetobacter genomic species 3.
AID1602730Inhibition of wild-type Streptococcus pneumoniae D39 ATP synthase atpE assessed as intracellular pH at 10 uM measured at 5 mins intervals by pH-sensitive GFP-based fluorescence assay (Rvb = 7.34 +/- 0.04 No_unit)2019Journal of medicinal chemistry, 03-14, Volume: 62, Issue:5
A Cinchona Alkaloid Antibiotic That Appears To Target ATP Synthase in Streptococcus pneumoniae.
AID1347836Induction of mitochondrial membrane potential loss in human HL60 cells after 24 hrs by JC-1 staining-based flow cytometry (Rvb = 24.3%)2018European journal of medicinal chemistry, Jan-01, Volume: 143Organic arsenicals target thioredoxin reductase followed by oxidative stress and mitochondrial dysfunction resulting in apoptosis.
AID572154Inhibition of Neisseria gonorrhoeae FA19 multidrug efflux protein NorM expressed in Escherichia coli AG100AX assessed as increase in ethidium bromide accumulation at 100 uM after 15 mins by fluorimetric assay2008Antimicrobial agents and chemotherapy, Sep, Volume: 52, Issue:9
Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.
AID554990Antibacterial activity against Acinetobacter genomosp. 3 isolate 65 by Etest method2009Antimicrobial agents and chemotherapy, Mar, Volume: 53, Issue:3
Genetic variability among ampC genes from acinetobacter genomic species 3.
AID1286340Increase in extracellular acidification rate in human HT-29 cells measured for 20 to 150 mins by time-resolved fluorescence assay relative to control2016Journal of natural products, Jan-22, Volume: 79, Issue:1
Amorfrutin C Induces Apoptosis and Inhibits Proliferation in Colon Cancer Cells through Targeting Mitochondria.
AID1323835Displacement of [3H]rosiglitazone from recombinant human C-terminal His-tagged MitoNEET cytosolic domain (32 to 108 residues) expressed in Escherichia coli BL21 by Cheng-Prusoff analysis2016Bioorganic & medicinal chemistry letters, 11-01, Volume: 26, Issue:21
Identification of small molecules that bind to the mitochondrial protein mitoNEET.
AID368421Antimicrobial activity against Escherichia coli KAM32 pSTV28 containing chloramphenicol-resistant vector by agar dilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
AID1555454Induction of mitochondrial membrane depolarization in Trypanosoma cruzi strain Y trypomastigotes assessed as reduction in mitochondrial membrane potential at 50 uM measured after 120 mins by JC-1 probe based flow cytometry2019European journal of medicinal chemistry, Aug-15, Volume: 176Dehydrodieugenol B derivatives as antiparasitic agents: Synthesis and biological activity against Trypanosoma cruzi.
AID537734Antifungal activity against yeast AD1-8u expressing Candida albicans CaMdr1p by agar disk diffusion assay2010European journal of medicinal chemistry, Nov, Volume: 45, Issue:11
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
AID1138445Induction of mitochondrial membrane depolarization in human U-343 MGa cells at 3 uM for 15 mins by cell fluo-analyzer relative to control2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
Structure-activity relationship refinement and further assessment of 4-phenylquinazoline-2-carboxamide translocator protein ligands as antiproliferative agents in human glioblastoma tumors.
AID1867978Antibacterial activity against Gram-negative Escherichia coli K-12 AG100 expressing AcrAB-TolC efflux pump assessed as inhibition of efflux pump by measuring intracellular accumulation of ethidium bromide at 50 uM and measured every minute for 1 hr by flu2022European journal of medicinal chemistry, Jul-05, Volume: 237Application of partially aromatic ortho-quionone-methides for the synthesis of novel naphthoxazines with improved antibacterial activity.
AID1063476Antibacterial activity against Bacteroides fragilis ATCC 25285 assessed as growth inhibition after 20 to 24 hrs2014Bioorganic & medicinal chemistry letters, Jan-15, Volume: 24, Issue:2
Diarylacylhydrazones: Clostridium-selective antibacterials with activity against stationary-phase cells.
AID1347815Induction of mitochondrial membrane potential loss in human HL60 cells after 24 hrs by JC-1 staining-based flow cytometry (Rvb = 28.6%)2018European journal of medicinal chemistry, Jan-01, Volume: 143Organic arsenicals target thioredoxin reductase followed by oxidative stress and mitochondrial dysfunction resulting in apoptosis.
AID1355394Disruption of cell membrane potential in Mycobacterium bovis BCG ATCC 35734 at 100 uM after 20 mins to 5 days by DiOC2 dye-based fluorescence assay2018Journal of medicinal chemistry, 07-12, Volume: 61, Issue:13
Indolyl Azaspiroketal Mannich Bases Are Potent Antimycobacterial Agents with Selective Membrane Permeabilizing Effects and in Vivo Activity.
AID368423Antimicrobial activity against Escherichia coli KAM32 pSTVdeltaqepA containing disrupted qepA gene by agar dilution method2007Antimicrobial agents and chemotherapy, Sep, Volume: 51, Issue:9
New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (2,250)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990820 (36.44)18.7374
1990's579 (25.73)18.2507
2000's438 (19.47)29.6817
2010's323 (14.36)24.3611
2020's90 (4.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 28.85

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index28.85 (24.57)
Research Supply Index7.75 (2.92)
Research Growth Index4.42 (4.65)
Search Engine Demand Index40.78 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (28.85)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (0.04%)5.53%
Reviews15 (0.65%)6.00%
Case Studies3 (0.13%)4.05%
Observational0 (0.00%)0.25%
Other2,289 (99.18%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]